Appetite For Korean Biotechs Turns Sour, Voronoi Withdraws IPO

Bioventure Floats Drop In 1Q

disappointment
Korea Exchange Increasingly Turns Down Bioventure IPO Approvals • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia